Argenx
ARGX
$365.81
Share price
-2.87%
Change (1 day)
-11.41%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: $21.74 Billion
As of May 2024 Argenx has a market cap of $21.74 Billion. This makes Argenx the world's 882th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Argenx from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $21.74 B | -3.66% |
| 2023 | $22.56 B | 7.67% |
| 2022 | $20.95 B | 13.96% |
| 2021 | $18.39 B | 31.15% |
| 2020 | $14.02 B | 103.85% |
| 2019 | $6.87 B | 96.18% |
| 2018 | $3.50 B | 74.88% |
| 2017 | $2.00 B | |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Argenx was reported to be:
$21.74 Billion
$21.74 Billion
$21.65 Billion
$21.75 Billion